"I was on and off (the medication) and now completely on," she told the "Today" show
A 20% relative risk reduction in MACE, including myocardial infarction, stroke, and cardiovascular death and a 30% relative risk reduction in hospitalizations for HF ( The VERTIS trial, involving 8246 patients with T2DM, compared ertugliflozin 5 mg or 15 mg daily to placebo for 3.5 years
298 In addition, IVIGs seem to increase the incidence of several serious adverse events in ARDS patients, such as septic shock, acute kidney injury, and bacterial pneumonia
31 GarofaloT.ManganelliV.GrassoM.MatteiV.FerriA.MisasiR.et al (2015)
This study reports two randomized, phase III clinical trials that showed that HIF-PHDi vadadustat was non-inferior to darbepoetin alfa in cardiovascular safety and efficacy in correcting anaemia in patients with CKD undergoing dialysis